Linaclotide vs Plecanatide
How they differ
- FDA status, the same for both (FDA-approved). Linaclotide: FDA-approved as Linzess.1,2 Plecanatide: FDA-approved as Trulance.3,4
Each row below repeats what the two profiles cite. It is not a ranking or a recommendation.
Side by side
| Topic | Linaclotide | Plecanatide |
|---|---|---|
| What it is | A guanylate cyclase-C agonist that the label says acts locally on the lining of the intestine.1 | A guanylate cyclase-C agonist and structural analogue of uroguanylin that the label says acts locally on the lining of the intestine.3 |
| FDA status | FDA-approved FDA-approved. Drugs@FDA lists Linzess with an original approval date of August 30, 2012. The label carries a boxed warning about serious dehydration in children younger than 2.1,2 | FDA-approved FDA-approved. Drugs@FDA lists Trulance with an original approval date of January 19, 2017. The label carries a boxed warning about serious dehydration in children.3,4 |
| HHS compounding policy, October 30, 2026 | Not among the six peptides the policy lists.5 | Not among the six peptides the policy lists.5 |
| FDA compounding safety-risk page | Not addressed in this profile’s sources. | Not addressed in this profile’s sources. |
| Kinds of studies cited |
|
|
| Records collected | 15 ClinicalTrials.gov records and 49 PubMed records collected | 12 ClinicalTrials.gov records and 16 PubMed records collected |
| Area of study | ||
| Latest dated events |
PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.
Citations
Sources
Numbered markers in the text point here. Each link opens the original public record.
- 1LINZESS (linaclotide) capsule · SPL version 39 · published 2026-06-01 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 2Drugs@FDA application NDA202811 · original submission status AP · 2012-08-30 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 3TRULANCE (plecanatide) tablet · SPL version 15 · published 2024-04-05 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 4Drugs@FDA application NDA208745 · original submission status AP · 2017-01-19 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 5HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, with Appendix A (list of peptides) and Appendix B (identities and justifications) ↗
U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026
- 6Drugs@FDA application ANDA209564 · original submission status AP · 2021-02-09 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026